Clinical Trials Browser

Phase 1/2 × Pancreatic Neoplasms × sintilimab × Clear all

NCT06572813 2025-01-10

CISPD-7

Phase 1/2 Recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT06761027 2025-01-07

mFOLFIRINOX Plus Anlotinib and Sintilimab for Advanced Pancreatic Cancer

Phase 1/2 Recruiting

Gastrointestinal

Pancreatic Neoplasms